Home/Filings/4/0001209191-22-014077
4//SEC Filing

York Michael 4

Accession 0001209191-22-014077

CIK 0001634379other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 4:55 PM ET

Size

7.5 KB

Accession

0001209191-22-014077

Insider Transaction Report

Form 4
Period: 2022-02-27
York Michael
Chief Business Officer
Transactions
  • Award

    Stock option (right to buy)

    2022-02-27+210,553210,553 total
    Exercise: $0.47Exp: 2032-02-26Common Stock (210,553 underlying)
  • Award

    Common Stock

    2022-02-27+210,553210,553 total
Footnotes (2)
  • [F1]Represents the number of shares of Common Stock issued to the Reporting Person pursuant to an award of restricted stock units. The award vests in full on February 27, 2023, subject to the Reporting Person's continued service to the Issuer.
  • [F2]50% of the shares of Common Stock subject to the stock option shall vest and become exercisable on February 27, 2023, and the remaining shares shall vest and become exercisable in equal installments on the last day of each of the following 12 months until fully vested on February 27, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Issuer

Metacrine, Inc.

CIK 0001634379

Entity typeother

Related Parties

1
  • filerCIK 0001755422

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:55 PM ET
Size
7.5 KB